Women fighting an aggressive form of breast cancer may benefit from adding certain drugs to their chemotherapy regimen, and taking them prior to surgery, new research finds. This pre-surgical drug therapy boosts the likelihood that no ...
Merck Serono has signed a license agreement with the Spanish National Cancer Research Centre (CNIO) in Madrid in the area of cancer drug development and will build upon CNIO research discoveries to support the development and ...
Tags: Cancer Patients, Merck Serono
A novel microfluidics device by IBM could be a boon to the oncology market. The new device can assist oncologists in identifying different types of cancer, offering several improvements over existing biopsy techniques. When a patient has ...
Tags: Health, Medicine, Microfluidics Device
Investors apparently like the potential for the ViewRay system — a combo of simultaneous MRI and radiation therapy delivery that has already been acquired by major five cancer treatment centers worldwide. Cleveland–based ...
Sutro Biopharma has received $26m in a Series D financing, which will be used for the expansion of its proprietary immuno-oncology product pipeline. The company is currently using its cell-free protein synthesis technology to develop new ...
Analog semiconductor maker Skyworks Solutions Inc of Woburn, MA, USA says that its subsidiary Isolink in Milpitas, CA is shipping customized optical solutions to Varian Medical Systems Inc of Palo Alto, CA for radiation oncology ...
US-based life sciences venture capital firm Versant Ventures is expanding its operations into Canada in order to invest in early-stage drug discovery programs. The company has established an office in Vancouver this year and created a new ...
Tags: Versant Ventures, Drug Discovery
Covagen has announced that the company has secured CHF42m in a tranched Series B financing with an option to obtain an additional CHF14m that would increase the total amount of the financing round to CHF56m. This financing will mainly ...
Foundation Medicine, a molecular information company, has announced the launch of its second clinical product, FoundationOne Heme, a fully informative genomic profile for hematologic cancers (leukemia, lymphoma and myeloma), as well as many ...
The US Food and Drug Administration (FDA) has granted orphan drug status for Teva Pharmaceutical's Treanda injection through October 2015 for indolent B-cell non-Hodgkin lymphoma (iNHL) that has progressed during or within six months of ...
VBL Therapeutics has secured fast track status from the US Food and Drug Administration (FDA) for its lead oncology drug VB-111, for prolongation of survival in patients with Recurrent Glioblastoma Multiforme (rGBM). VB-111 was already ...
US-based research and development biotechnology firm Boston Strategics has entered into a new drug development partnership with Fujifilm Pharmaceuticals USA (FPHU), a global pharmaceutical development center of Japan's Fujifilm Corporation. ...
Tags: Oncology Drugs, Fujifilm Pharma
Men with prostate cancer who ate a low-fat diet and took fish body oil supplements may have lower risk of cancer recurrence, U.S. researchers say. Lead author William Aronson of the University of California, Los Angeles, and chief of ...
Tags: Low-fat, diet, fish oil, supplement, prostate, cancer, recurrence
Germany-based Bayer HealthCare and US-based Onyx Pharmaceuticals have announced that the US Food and Drug Administration (FDA) has approved Nexavar (sorafenib), an oral multi-kinase inhibitor, for the treatment of patients with ...
US-based Moderna Therapeutics has announced the completion of a new financing round, raising $110m to develop messenger RNA Therapeutics. In aggregate, Moderna has secured more than $415m in financing and partnerships to date from the ...